SAN DIEGO, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Icon Vapor, Inc. (OTC:ICNV) announced today its filing of the required documents to qualify it for a fully reporting status (QB) on the OTC Markets Exchange.
ICON Vapor President Dan Balsiger announced today, "We are pursuing a number of new initiatives that will be better served through advancing our listing to that of a fully reporting company. To that end we have filed the requisite documents with the exchange and SEC that we believe will allow us to qualify for that listing level."
Mr. Balsiger further noted, "We expect to complete this process in the next thirty to sixty days and look forward to providing additional positive news related to our progress as we approach the end of FY 2014 in advancing our brand's reach and revenue generation potentials."
About ICON Vapor, Inc. (www.IconVapor.com)
Headquartered in San Diego, California, Icon Vapor engages in the manufacture and distribution of electronic cigarettes. The company offers disposable and starter kits e-cigarettes as well as cartomizers in tobacco and menthol flavors branded under the ICON Vapor Products line. For further information please contact the Company at:
(858.509.2783 or Sales@IconVapor.com)
Safe Harbor Statement
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.